Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andreas Seeber"'
Autor:
Dominik Wolf, Andreas Seeber, Katharina Kurz, Florian Kocher, Arno Amann, Kai Zimmer, Andreas Pircher, Simon Geisler, Dietmar Fuchs, Renate Pichler
Publikováno v:
Transl Lung Cancer Res
Background Metabolic profiling in non-small cell lung cancer (NSCLC) may identify key metabolic vulnerabilities and shows enormous discovery potential. Preclinical studies showed that metabolic rewiring in cancer plays an essential role in modulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5923d44bf0b8893b1c0b7a7f06a07d
https://europepmc.org/articles/PMC7867793/
https://europepmc.org/articles/PMC7867793/
Autor:
Sadaqat Hussain, Dario Trapani, Dominik Wolf, Sara Cecilia Altuna Mujica, Shahzeb Khan, Ella Willenbacher, Gilbert Spizzo, Andreas Seeber, Wolfgang Willenbacher
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 5725, p 5725 (2020)
We would like to change the authors’ names and affiliations on Page 1 of paper [...]
Autor:
Jalid Sehouli, Guenther Gastl, Dominic Fong, Laura Botta, Andreas Seeber, Gilbert Spizzo, Alain G. Zeimet, Mani Nassir, Gerold Untergasser, Heidi Fiegl, Ioana Braicu
Publikováno v:
Oncotarget
EpCAM is an attractive target for cancer therapy and the EpCAM-specific antibody catumaxomab has been used for intraperitoneal treatment of EpCAM-positive cancer patients with malignant ascites. New prognostic markers are necessary to select patients
Autor:
Guido Mazzoleni, Guenther Gastl, Florian Lehne, Andreas Seeber, Gilbert Spizzo, Armin Kasal, Luigi Terracciano, Dominic Fong
Publikováno v:
Journal of Clinical Pathology
Aims Regulated intramembrane proteolysis has been shown to be an important mechanism for oncogenic activation of epithelial cell adhesion molecule (EpCAM) through nuclear translocation of the intracellular domain EpICD. Recent studies have identified